Histamine H2-RECEPTOR antagonists

Intervention1 paper1 finding

C · W · M · H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

1 of 1 finding with company ties

  • Humans1

Outcomes

1

Age-related macular degeneration

no changein humans1

1 study
  1. Histamine H2-RECEPTOR antagonists have no effect on age-related macular degeneration in humans (sHR 1.02, 95% CI 0.88 to 1.19).

    Humans

    Sustained proton-pump inhibitor exposure and incident age-related macular degeneration: a new-user, population-based cohort study · BMJ open ophthalmology · 23 Sep 2026

Age-related macular degeneration →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01